NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia

Background MicroRNA miR‐214 has been implicated in many biological cellular functions, but the impact of miR‐214 and its target genes on vascular smooth muscle cell (VSMC) proliferation, migration, and neointima smooth muscle cell hyperplasia is unknown. Methods and Results Expression of miR‐214 was...

Full description

Saved in:
Bibliographic Details
Main Authors: Tayyab Adeel Afzal, Le Anh Luong, Dan Chen, Cheng Zhang, Feng Yang, Qishan Chen, Weiwei An, Edmund Wilkes, Kenta Yashiro, Pedro R. Cutillas, Li Zhang, Qingzhong Xiao
Format: Article
Language:English
Published: Wiley 2016-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.004629
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839639852260261888
author Tayyab Adeel Afzal
Le Anh Luong
Dan Chen
Cheng Zhang
Feng Yang
Qishan Chen
Weiwei An
Edmund Wilkes
Kenta Yashiro
Pedro R. Cutillas
Li Zhang
Qingzhong Xiao
author_facet Tayyab Adeel Afzal
Le Anh Luong
Dan Chen
Cheng Zhang
Feng Yang
Qishan Chen
Weiwei An
Edmund Wilkes
Kenta Yashiro
Pedro R. Cutillas
Li Zhang
Qingzhong Xiao
author_sort Tayyab Adeel Afzal
collection DOAJ
description Background MicroRNA miR‐214 has been implicated in many biological cellular functions, but the impact of miR‐214 and its target genes on vascular smooth muscle cell (VSMC) proliferation, migration, and neointima smooth muscle cell hyperplasia is unknown. Methods and Results Expression of miR‐214 was closely regulated by different pathogenic stimuli in VSMCs through a transcriptional mechanism and decreased in response to vascular injury. Overexpression of miR‐214 in serum‐starved VSMCs significantly decreased VSMC proliferation and migration, whereas knockdown of miR‐214 dramatically increased VSMC proliferation and migration. Gene and protein biochemical assays, including proteomic analyses, showed that NCK associated protein 1 (NCKAP1)—a major component of the WAVE complex that regulates lamellipodia formation and cell motility—was negatively regulated by miR‐214 in VSMCs. Luciferase assays showed that miR‐214 substantially repressed wild‐type but not the miR‐214 binding site mutated version of NCKAP1 3′ untranslated region luciferase activity in VSMCs. This result confirmed that NCKAP1 is the functional target of miR‐214 in VSMCs. NCKAP1 knockdown in VSMCs recapitulates the inhibitory effects of miR‐214 overexpression on actin polymerization, cell migration, and proliferation. Data from cotransfection experiments also revealed that inhibition of NCKAP1 is required for miR‐214–mediated lamellipodia formation, cell motility, and growth. Importantly, locally enforced expression of miR‐214 in the injured vessels significantly reduced NCKAP1 expression levels, inhibited VSMC proliferation, and prevented neointima smooth muscle cell hyperplasia after injury. Conclusions We uncovered an important role of miR‐214 and its target gene NCKAP1 in modulating VSMC functions and neointima hyperplasia. Our findings suggest that miR‐214 represents a potential therapeutic target for vascular diseases.
format Article
id doaj-art-c097f5e8833a422f8ca7136bf9b42aa0
institution Matheson Library
issn 2047-9980
language English
publishDate 2016-12-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-c097f5e8833a422f8ca7136bf9b42aa02025-07-04T05:15:20ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802016-12-0151210.1161/JAHA.116.004629NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima HyperplasiaTayyab Adeel Afzal0Le Anh Luong1Dan Chen2Cheng Zhang3Feng Yang4Qishan Chen5Weiwei An6Edmund Wilkes7Kenta Yashiro8Pedro R. Cutillas9Li Zhang10Qingzhong Xiao11Centre for Clinical Pharmacology William Harvey Research Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomCentre for Clinical Pharmacology William Harvey Research Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomCentre for Clinical Pharmacology William Harvey Research Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomCentre for Clinical Pharmacology William Harvey Research Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomCentre for Clinical Pharmacology William Harvey Research Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomCentre for Clinical Pharmacology William Harvey Research Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomCentre for Clinical Pharmacology William Harvey Research Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomCentre for Haemato‐Oncology Barts Cancer Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomTranslational Medicine & Therapeutics William Harvey Research Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomCentre for Haemato‐Oncology Barts Cancer Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomDepartment of Cardiology The First Affiliated Hospital School of Medicine Zhejiang University Hangzhou Zhejiang ChinaCentre for Clinical Pharmacology William Harvey Research Institute Barts and The London School of Medicine and Dentistry Queen Mary University of London United KingdomBackground MicroRNA miR‐214 has been implicated in many biological cellular functions, but the impact of miR‐214 and its target genes on vascular smooth muscle cell (VSMC) proliferation, migration, and neointima smooth muscle cell hyperplasia is unknown. Methods and Results Expression of miR‐214 was closely regulated by different pathogenic stimuli in VSMCs through a transcriptional mechanism and decreased in response to vascular injury. Overexpression of miR‐214 in serum‐starved VSMCs significantly decreased VSMC proliferation and migration, whereas knockdown of miR‐214 dramatically increased VSMC proliferation and migration. Gene and protein biochemical assays, including proteomic analyses, showed that NCK associated protein 1 (NCKAP1)—a major component of the WAVE complex that regulates lamellipodia formation and cell motility—was negatively regulated by miR‐214 in VSMCs. Luciferase assays showed that miR‐214 substantially repressed wild‐type but not the miR‐214 binding site mutated version of NCKAP1 3′ untranslated region luciferase activity in VSMCs. This result confirmed that NCKAP1 is the functional target of miR‐214 in VSMCs. NCKAP1 knockdown in VSMCs recapitulates the inhibitory effects of miR‐214 overexpression on actin polymerization, cell migration, and proliferation. Data from cotransfection experiments also revealed that inhibition of NCKAP1 is required for miR‐214–mediated lamellipodia formation, cell motility, and growth. Importantly, locally enforced expression of miR‐214 in the injured vessels significantly reduced NCKAP1 expression levels, inhibited VSMC proliferation, and prevented neointima smooth muscle cell hyperplasia after injury. Conclusions We uncovered an important role of miR‐214 and its target gene NCKAP1 in modulating VSMC functions and neointima hyperplasia. Our findings suggest that miR‐214 represents a potential therapeutic target for vascular diseases.https://www.ahajournals.org/doi/10.1161/JAHA.116.004629cell migrationcell proliferationmicroRNAmiRNA‐214NCK‐associated protein 1neointimal hyperplasia
spellingShingle Tayyab Adeel Afzal
Le Anh Luong
Dan Chen
Cheng Zhang
Feng Yang
Qishan Chen
Weiwei An
Edmund Wilkes
Kenta Yashiro
Pedro R. Cutillas
Li Zhang
Qingzhong Xiao
NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
cell migration
cell proliferation
microRNA
miRNA‐214
NCK‐associated protein 1
neointimal hyperplasia
title NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia
title_full NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia
title_fullStr NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia
title_full_unstemmed NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia
title_short NCK Associated Protein 1 Modulated by miRNA‐214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia
title_sort nck associated protein 1 modulated by mirna 214 determines vascular smooth muscle cell migration proliferation and neointima hyperplasia
topic cell migration
cell proliferation
microRNA
miRNA‐214
NCK‐associated protein 1
neointimal hyperplasia
url https://www.ahajournals.org/doi/10.1161/JAHA.116.004629
work_keys_str_mv AT tayyabadeelafzal nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT leanhluong nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT danchen nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT chengzhang nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT fengyang nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT qishanchen nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT weiweian nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT edmundwilkes nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT kentayashiro nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT pedrorcutillas nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT lizhang nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia
AT qingzhongxiao nckassociatedprotein1modulatedbymirna214determinesvascularsmoothmusclecellmigrationproliferationandneointimahyperplasia